Investors were encouraged not only by the company's latest quarterly growth rates, but also its latest news about share ...

CMS Reimbursement Codes -- The Centers for Medicare & Medicaid Services (CMS) approved dedicated CPT codes for superficial ...

Despite posting growth in October, the company was hit with a mild analyst price target reduction.

Guidance Affirmed -- Full-year fiscal 2025 guidance remains intact: consolidated adjusted EBITDA projected at $60-$65 million ...

Active 3P Seller Base -- Rose 17% year-over-year for the trailing twelve months ending September 30, 2025 to 1,232, with ...

The U.S. stock market turned sharply lower Tuesday morning in reaction to seemingly negative comments by the CEOs of Morgan ...

Fueled by gains in all of its therapeutic areas, the company had a triumphant third quarter.

The company's 2025 forecast left something to be desired.

CarMax is navigating multiple challenges. The company's CEO has announced his upcoming retirement on December 1st; management ...

2025 Guidance Update -- Revenue guidance set at $870 million to $880 million and adjusted EBITDA guidance set at $164 million ...

Nvidia is the most valuable company in the world, and it's not cheap. It trades at a P/E ratio of 53 and a price-to-sales ...

The shortage in memory supply is also boosting Micron's margins and earnings performance. Adjusted earnings per share jumped ...